Reference 15 - Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients
FDA-2026-P-6541-0017Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- Reference 15 - Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients
- Posted
- Jun 9, 2026
- Topics